Evidence map›Paper›PMID 35739106›Full record

ArticleNature communications2022

In situ 3D bioprinting with bioconcrete bioink.

Mingjun Xie, Yang Shi, Chun Zhang, Mingjie Ge, Jingbo Zhang, Zichen Chen, Jianzhong Fu, Zhijian Xie, Yong He

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. [Microfluidic photo-curing fabrication of silk fibroin/hyaluronic acid composite microsphere hydrogels].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Article
  15. Article
  16. Imaging-Guided Microscale Photothermal Stereolithography Bioprinting.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  17. Review
  18. Bioactive materials · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mingjun Xie *State Key Laboratory of Fluid Power and Mechatronic Systems, School of Mechanical Engineering, Zhejiang University, 310027, Hangzhou, China.ORCID 0000-0003-3801-6510
Yang Shi *Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, 310006, Hangzhou, China.
Chun ZhangStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, 310006, Hangzhou, China.ORCID 0000-0003-3502-5091
Mingjie GeStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, 310006, Hangzhou, China.
Jingbo ZhangState Key Laboratory of Fluid Power and Mechatronic Systems, School of Mechanical Engineering, Zhejiang University, 310027, Hangzhou, China.
Zichen ChenState Key Laboratory of Fluid Power and Mechatronic Systems, School of Mechanical Engineering, Zhejiang University, 310027, Hangzhou, China.
Jianzhong FuState Key Laboratory of Fluid Power and Mechatronic Systems, School of Mechanical Engineering, Zhejiang University, 310027, Hangzhou, China.
Zhijian XieStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, 310006, Hangzhou, China.ORCID 0000-0003-0122-0948
Yong HeState Key Laboratory of Fluid Power and Mechatronic Systems, School of Mechanical Engineering, Zhejiang University, 310027, Hangzhou, China. yongqin@zju.edu.cn.ORCID 0000-0002-9099-0831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In-situ bioprinting is attractive for directly depositing the therapy bioink at the defective organs to repair them, especially for occupations such as soldiers, athletes, and drivers who can be injured in emergency. However, traditional bioink displays obvious limitations in its complex operation environments. Here, we design a bioconcrete bioink with electrosprayed cell-laden microgels as the aggregate and gelatin methacryloyl (GelMA) precursor solution as the cement. Promising printability is guaranteed with a wide temperature range benefiting from robust rheological properties of photocrosslinked microgel aggregate and fluidity of GelMA cement. Composite components simultaneously self-adapt to biocompatibility and different tissue mechanical microenvironment. Strong binding on tissue-hydrogel interface is achieved by hydrogen bonds and friction when the cement is photocrosslinked. This bioink owns good portability and can be easily prepared in urgent accidents. Meanwhile, microgels can be cultured to mini tissues and then mixed as bioink aggregates, indicating our bioconcrete can be functionalized faster than normal bioinks. The cranial defects repair results verify the superiority of this bioink and its potential in clinical settings required in in-situ treatment.

Indexed as

BioprintingMicrogelsGelatinHumansHydrogelsMethacrylatesPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsGelatingelatin methacryloylHydrogelsMethacrylatesMicrogels

Identifiers

PMID35739106
PMCPMC9225998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.